These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3941330)

  • 1. Fatal complications from combined modality therapy in Hodgkin's disease: age is not a risk factor.
    Gomez GA
    J Clin Oncol; 1986 Jan; 4(1):114-5. PubMed ID: 3941330
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease in children.
    Pao WJ; Kun LE
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):345-65. PubMed ID: 2663832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of fatal complications from combined modality therapy in Hodgkin's disease.
    Mauch PM; Canellos GP; Rosenthal DS; Hellman S
    J Clin Oncol; 1985 Apr; 3(4):501-5. PubMed ID: 3872348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hodgkin's disease in children. Clinical and therapeutic peculiarities].
    Oberlin O; Bayle C; Lemerle J
    Rev Prat; 1984 Apr; 34(21):1081-4. PubMed ID: 6718983
    [No Abstract]   [Full Text] [Related]  

  • 6. Occurrence of herpes zoster varicella infections after completion of treatment for Hodgkin's disease.
    De Pauw BE; Janssen JT; Vaissier P; Haanen C
    Neth J Med; 1983; 26(10):301-3. PubMed ID: 6656975
    [No Abstract]   [Full Text] [Related]  

  • 7. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary malignancies following treatment of Hodgkin's disease].
    Wijlhuizen TJ; Breed WP
    Ned Tijdschr Geneeskd; 1987 Aug; 131(31):1342-6. PubMed ID: 3477701
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hodgkin's disease. The cure and its price].
    Jacquillat C; Auclerc G; Auclerc MF; Weil M
    Rev Prat; 1984 Apr; 34(21):1075-80. PubMed ID: 6718982
    [No Abstract]   [Full Text] [Related]  

  • 10. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study.
    Ali A; Sayed H; Farrag A; El-Sayed M
    Leuk Res; 2010 Nov; 34(11):1447-52. PubMed ID: 20599270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
    Tester WJ; Kinsella TJ; Waller B; Makuch RW; Kelley PA; Glatstein E; DeVita VT
    J Clin Oncol; 1984 Jul; 2(7):762-9. PubMed ID: 6547479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second tumors following treatment of Hodgkin's disease].
    Somers R; van Leeuwen FE; Taal BG; van Heerde P; Coster B; Hart AA
    Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1358-62. PubMed ID: 3412505
    [No Abstract]   [Full Text] [Related]  

  • 16. Retroperitoneal fibrosis following treatment for Hodgkin's disease.
    Chao N; Levine J; Horning SJ
    J Clin Oncol; 1987 Feb; 5(2):231-2. PubMed ID: 3100728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major complications and causes of death in patients treated for Hodgkin's disease.
    van Rijswijk RE; Verbeek J; Haanen C; Dekker AW; van Daal WA; van Peperzeel HA
    J Clin Oncol; 1987 Oct; 5(10):1624-33. PubMed ID: 3655860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hodgkin's disease; a regional retrospective study].
    Erdkamp FL; Wijlhuizen TJ; van Dam FE
    Ned Tijdschr Geneeskd; 1988 Sep; 132(39):1801-6. PubMed ID: 3141820
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hodgkin's lymphoma].
    Jyrkkiio S; Mokka M; Vasala K
    Duodecim; 2014; 130(9):913-20. PubMed ID: 24881143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
    Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
    J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.